PharmaLundensis AB (XSAT:PHAL BTA) Other Stockholders Equity : kr2.22 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is PharmaLundensis AB Other Stockholders Equity?

PharmaLundensis AB's Other Stockholders Equity for the quarter that ended in Mar. 2025 was kr2.22 Mil.

PharmaLundensis AB's quarterly Other Stockholders Equity increased from Sep. 2024 (kr1.75 Mil) to Dec. 2024 (kr2.22 Mil) but then declined from Dec. 2024 (kr2.22 Mil) to Mar. 2025 (kr2.22 Mil).

PharmaLundensis AB's annual Other Stockholders Equity declined from Dec. 2022 (kr2.98 Mil) to Dec. 2023 (kr0.80 Mil) but then increased from Dec. 2023 (kr0.80 Mil) to Dec. 2024 (kr2.22 Mil).

PharmaLundensis AB Other Stockholders Equity Historical Data

The historical data trend for PharmaLundensis AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaLundensis AB Other Stockholders Equity Chart

PharmaLundensis AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Get a 7-Day Free Trial

1.96

2.37

2.98

0.80

2.22

PharmaLundensis AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Stockholders Equity	Get a 7-Day Free Trial															0.80	1.27	1.75	2.22	2.22

PharmaLundensis AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

PharmaLundensis AB Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaLundensis AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL BTA) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

PHAL:Sweden

Address

PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63

Website

http://www.pharmalundensis.se

PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB Headlines

No Headlines